Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More Analysis and Commentary STEVEN GROSSMAN 10/1/20 Analysis and Commentary STEVEN GROSSMAN 10/1/20 Understanding the Short-Term CR Read More Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More Advocacy at a Glance STEVEN GROSSMAN 9/25/20 Advocacy at a Glance STEVEN GROSSMAN 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More Analysis and Commentary STEVEN GROSSMAN 8/14/20 Analysis and Commentary STEVEN GROSSMAN 8/14/20 "Somehow the CR Will Pass", But When? Read More Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Party Platforms Don’t Matter, Probably Read More Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Advocacy at a Glance STEVEN GROSSMAN 8/1/20 Advocacy at a Glance STEVEN GROSSMAN 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More Advocacy at a Glance STEVEN GROSSMAN 7/26/20 Advocacy at a Glance STEVEN GROSSMAN 7/26/20 FY 21 Appropriation: Qs&As Read More Analysis and Commentary STEVEN GROSSMAN 4/24/20 Analysis and Commentary STEVEN GROSSMAN 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More Analysis and Commentary STEVEN GROSSMAN 12/8/19 Analysis and Commentary STEVEN GROSSMAN 12/8/19 Three Key Questions ... and the Answers Read More Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More
Analysis and Commentary STEVEN GROSSMAN 10/1/20 Analysis and Commentary STEVEN GROSSMAN 10/1/20 Understanding the Short-Term CR Read More
Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More
Advocacy at a Glance STEVEN GROSSMAN 9/25/20 Advocacy at a Glance STEVEN GROSSMAN 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More
Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Advocacy at a Glance STEVEN GROSSMAN 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More
Analysis and Commentary STEVEN GROSSMAN 8/14/20 Analysis and Commentary STEVEN GROSSMAN 8/14/20 "Somehow the CR Will Pass", But When? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Party Platforms Don’t Matter, Probably Read More
Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Advocacy at a Glance STEVEN GROSSMAN 8/1/20 Advocacy at a Glance STEVEN GROSSMAN 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More
Advocacy at a Glance STEVEN GROSSMAN 7/26/20 Advocacy at a Glance STEVEN GROSSMAN 7/26/20 FY 21 Appropriation: Qs&As Read More
Analysis and Commentary STEVEN GROSSMAN 4/24/20 Analysis and Commentary STEVEN GROSSMAN 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More
Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Advocacy at a Glance STEVEN GROSSMAN 4/3/20 Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 12/8/19 Analysis and Commentary STEVEN GROSSMAN 12/8/19 Three Key Questions ... and the Answers Read More
Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More
Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More
Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More
Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More
